Table of contents

June 2018 - Volume 3 - 3


A

  1. Aguilar, Alfredo

    1. Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
      Joseph A Pinto, Carlos S Vallejos, Luis E Raez, Luis A Mas, Rossana Ruiz, Junior S Torres-Roman, Zaida Morante, Jhajaira M Araujo, Henry L Gómez, Alfredo Aguilar, Denisse Bretel, Claudio J Flores, Christian Rolfo
  2. Alt, Marie

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  3. Araujo, Jhajaira M

    1. Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
      Joseph A Pinto, Carlos S Vallejos, Luis E Raez, Luis A Mas, Rossana Ruiz, Junior S Torres-Roman, Zaida Morante, Jhajaira M Araujo, Henry L Gómez, Alfredo Aguilar, Denisse Bretel, Claudio J Flores, Christian Rolfo
  4. Ardin, Maude

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  5. Ariansen, Sarah Louise

    1. BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
      Jan Norum, Eli Marie Grindedal, Cecilie Heramb, Inga Karsrud, Sarah Louise Ariansen, Dag Erik Undlien, Ellen Schlichting, Lovise Mæhle

B

  1. Bando, Hiroyuki

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  2. Basse, Clémence

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  3. Bataillon, Guillaume

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  4. Batistatou, Anna

    1. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece
      Leonidas Mavroeidis, Vassiliki Metaxa-Mariatou, Alexandra Papoudou-Bai, Angeliki Maria Lampraki, Lida Kostadima, Ilias Tsinokou, George Zarkavelis, Alexandra Papadaki, Dimitrios Petrakis, Stefania Gκoura, Eleftherios Kampletsas, George Nasioulas, Anna Batistatou, George Pentheroudakis
  5. Benoist, Camille

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  6. Bernard, Virginie

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  7. Bieche, Ivan

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  8. Bodoky, Gyorgy

    1. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero
  9. Bonsang, Benjamin

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  10. Bretel, Denisse

    1. Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
      Joseph A Pinto, Carlos S Vallejos, Luis E Raez, Luis A Mas, Rossana Ruiz, Junior S Torres-Roman, Zaida Morante, Jhajaira M Araujo, Henry L Gómez, Alfredo Aguilar, Denisse Bretel, Claudio J Flores, Christian Rolfo
  11. Bruixola, Gemma

    1. In the literature: April 2018
      Valentina Gambardella, Gemma Bruixola, Andrés Cervantes

C

  1. Callens, Céline

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  2. Castro, Jenny Lissette

    1. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016
      Roberto Ivan López, Jenny Lissette Castro, Heidy Cedeño, Dagoberto Cisneros, Luis Corrales, Ileana González-Herrera, Mayté Lima-Pérez, Rogelio Prestol, Roberto Salinas, Jorge Luis Soriano-García, Alejandra T Zavala, Luis Miguel Zetina, Carlos Eduardo Zúñiga-Orlich
  3. Cathomas, Richard

    1. Carboplatin dose based on actual renal function: no excess of acute haematotoxicity in adjuvant treatment in seminoma stage I
      Martin Fehr, Angela Fischer Maranta, Hermann Reichegger, Silke Gillessen, Richard Cathomas
  4. Cedeño, Heidy

    1. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016
      Roberto Ivan López, Jenny Lissette Castro, Heidy Cedeño, Dagoberto Cisneros, Luis Corrales, Ileana González-Herrera, Mayté Lima-Pérez, Rogelio Prestol, Roberto Salinas, Jorge Luis Soriano-García, Alejandra T Zavala, Luis Miguel Zetina, Carlos Eduardo Zúñiga-Orlich
  5. Cervantes, Andrés

    1. In the literature: April 2018
      Valentina Gambardella, Gemma Bruixola, Andrés Cervantes
  6. Chang, Young Hwan

    1. Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability
      Junhun Cho, Young Hwan Chang, You Jeong Heo, Seungtae Kim, Nayoung KD Kim, Joon Oh Park, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim
  7. Cho, Junhun

    1. Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability
      Junhun Cho, Young Hwan Chang, You Jeong Heo, Seungtae Kim, Nayoung KD Kim, Joon Oh Park, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim
  8. Cisneros, Dagoberto

    1. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016
      Roberto Ivan López, Jenny Lissette Castro, Heidy Cedeño, Dagoberto Cisneros, Luis Corrales, Ileana González-Herrera, Mayté Lima-Pérez, Rogelio Prestol, Roberto Salinas, Jorge Luis Soriano-García, Alejandra T Zavala, Luis Miguel Zetina, Carlos Eduardo Zúñiga-Orlich
  9. Ciuleanu, Tudor

    1. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero
  10. Clément, Nathalie

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  11. Corrales, Luis

    1. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016
      Roberto Ivan López, Jenny Lissette Castro, Heidy Cedeño, Dagoberto Cisneros, Luis Corrales, Ileana González-Herrera, Mayté Lima-Pérez, Rogelio Prestol, Roberto Salinas, Jorge Luis Soriano-García, Alejandra T Zavala, Luis Miguel Zetina, Carlos Eduardo Zúñiga-Orlich

D

  1. Dubot, Coraline

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal

E

  1. Eto, Tetsuya

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori

F

  1. Fehr, Martin

    1. Carboplatin dose based on actual renal function: no excess of acute haematotoxicity in adjuvant treatment in seminoma stage I
      Martin Fehr, Angela Fischer Maranta, Hermann Reichegger, Silke Gillessen, Richard Cathomas
  2. Ferry, David

    1. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero
  3. Flores, Claudio J

    1. Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
      Joseph A Pinto, Carlos S Vallejos, Luis E Raez, Luis A Mas, Rossana Ruiz, Junior S Torres-Roman, Zaida Morante, Jhajaira M Araujo, Henry L Gómez, Alfredo Aguilar, Denisse Bretel, Claudio J Flores, Christian Rolfo
  4. Franck, Coralie

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal

G

  1. Gambardella, Valentina

    1. In the literature: April 2018
      Valentina Gambardella, Gemma Bruixola, Andrés Cervantes
  2. Gamoh, Makio

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  3. Garcia-Carbonero, Rocio

    1. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero
  4. García-Alfonso, Pilar

    1. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero
  5. Gardrat, Sophie

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  6. Geiss, Romain

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  7. Gillessen, Silke

    1. Carboplatin dose based on actual renal function: no excess of acute haematotoxicity in adjuvant treatment in seminoma stage I
      Martin Fehr, Angela Fischer Maranta, Hermann Reichegger, Silke Gillessen, Richard Cathomas
  8. Girard, Elodie

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  9. González-Herrera, Ileana

    1. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016
      Roberto Ivan López, Jenny Lissette Castro, Heidy Cedeño, Dagoberto Cisneros, Luis Corrales, Ileana González-Herrera, Mayté Lima-Pérez, Rogelio Prestol, Roberto Salinas, Jorge Luis Soriano-García, Alejandra T Zavala, Luis Miguel Zetina, Carlos Eduardo Zúñiga-Orlich
  10. Grindedal, Eli Marie

    1. BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
      Jan Norum, Eli Marie Grindedal, Cecilie Heramb, Inga Karsrud, Sarah Louise Ariansen, Dag Erik Undlien, Ellen Schlichting, Lovise Mæhle
  11. Grothey, Axel

    1. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero
  12. Gómez, Henry L

    1. Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
      Joseph A Pinto, Carlos S Vallejos, Luis E Raez, Luis A Mas, Rossana Ruiz, Junior S Torres-Roman, Zaida Morante, Jhajaira M Araujo, Henry L Gómez, Alfredo Aguilar, Denisse Bretel, Claudio J Flores, Christian Rolfo
  13. Gκoura, Stefania

    1. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece
      Leonidas Mavroeidis, Vassiliki Metaxa-Mariatou, Alexandra Papoudou-Bai, Angeliki Maria Lampraki, Lida Kostadima, Ilias Tsinokou, George Zarkavelis, Alexandra Papadaki, Dimitrios Petrakis, Stefania Gκoura, Eleftherios Kampletsas, George Nasioulas, Anna Batistatou, George Pentheroudakis

H

  1. Hasegawa, Junichi

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  2. Heo, You Jeong

    1. Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability
      Junhun Cho, Young Hwan Chang, You Jeong Heo, Seungtae Kim, Nayoung KD Kim, Joon Oh Park, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim
  3. Heramb, Cecilie

    1. BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
      Jan Norum, Eli Marie Grindedal, Cecilie Heramb, Inga Karsrud, Sarah Louise Ariansen, Dag Erik Undlien, Ellen Schlichting, Lovise Mæhle
  4. Hoda, Mir Alireza

    1. Controversies in oncology: surgery for small cell lung cancer? It’s time to rethink the case
      Mir Alireza Hoda, Thomas Klikovits, Walter Klepetko
  5. Hsu, Yanzhi

    1. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero

K

  1. Kamal, Maud

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  2. Kamoun, Choumouss

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  3. Kampletsas, Eleftherios

    1. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece
      Leonidas Mavroeidis, Vassiliki Metaxa-Mariatou, Alexandra Papoudou-Bai, Angeliki Maria Lampraki, Lida Kostadima, Ilias Tsinokou, George Zarkavelis, Alexandra Papadaki, Dimitrios Petrakis, Stefania Gκoura, Eleftherios Kampletsas, George Nasioulas, Anna Batistatou, George Pentheroudakis
  4. Kang, Won Ki

    1. Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability
      Junhun Cho, Young Hwan Chang, You Jeong Heo, Seungtae Kim, Nayoung KD Kim, Joon Oh Park, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim
  5. Karamouzis, Michalis V

    1. Response: Effects of physical activity on depressive symptoms during breast cancer survivorship: a meta-analysis of randomised control trials
      Efrossini D Patsou, Michalis V Karamouzis
  6. Karsrud, Inga

    1. BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
      Jan Norum, Eli Marie Grindedal, Cecilie Heramb, Inga Karsrud, Sarah Louise Ariansen, Dag Erik Undlien, Ellen Schlichting, Lovise Mæhle
  7. Kato, Takeshi

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  8. Kim, Kyoung-Mee

    1. Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability
      Junhun Cho, Young Hwan Chang, You Jeong Heo, Seungtae Kim, Nayoung KD Kim, Joon Oh Park, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim
  9. Kim, Nayoung KD

    1. Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability
      Junhun Cho, Young Hwan Chang, You Jeong Heo, Seungtae Kim, Nayoung KD Kim, Joon Oh Park, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim
  10. Kim, Seungtae

    1. Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability
      Junhun Cho, Young Hwan Chang, You Jeong Heo, Seungtae Kim, Nayoung KD Kim, Joon Oh Park, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim
  11. Klepetko, Walter

    1. Controversies in oncology: surgery for small cell lung cancer? It’s time to rethink the case
      Mir Alireza Hoda, Thomas Klikovits, Walter Klepetko
  12. Klikovits, Thomas

    1. Controversies in oncology: surgery for small cell lung cancer? It’s time to rethink the case
      Mir Alireza Hoda, Thomas Klikovits, Walter Klepetko
  13. Kostadima, Lida

    1. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece
      Leonidas Mavroeidis, Vassiliki Metaxa-Mariatou, Alexandra Papoudou-Bai, Angeliki Maria Lampraki, Lida Kostadima, Ilias Tsinokou, George Zarkavelis, Alexandra Papadaki, Dimitrios Petrakis, Stefania Gκoura, Eleftherios Kampletsas, George Nasioulas, Anna Batistatou, George Pentheroudakis
  14. Kotaka, Masahito

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori

L

  1. Lambertini, Matteo

    1. Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?
      Matteo Lambertini, Giulia Viglietti, Evandro de Azambuja
  2. Lampraki, Angeliki Maria

    1. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece
      Leonidas Mavroeidis, Vassiliki Metaxa-Mariatou, Alexandra Papoudou-Bai, Angeliki Maria Lampraki, Lida Kostadima, Ilias Tsinokou, George Zarkavelis, Alexandra Papadaki, Dimitrios Petrakis, Stefania Gκoura, Eleftherios Kampletsas, George Nasioulas, Anna Batistatou, George Pentheroudakis
  3. Lavigne, Marion

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  4. Le Tourneau, Christophe

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  5. Lee, Jeeyun

    1. Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability
      Junhun Cho, Young Hwan Chang, You Jeong Heo, Seungtae Kim, Nayoung KD Kim, Joon Oh Park, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim
  6. Li, Li

    1. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero
  7. Lima-Pérez, Mayté

    1. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016
      Roberto Ivan López, Jenny Lissette Castro, Heidy Cedeño, Dagoberto Cisneros, Luis Corrales, Ileana González-Herrera, Mayté Lima-Pérez, Rogelio Prestol, Roberto Salinas, Jorge Luis Soriano-García, Alejandra T Zavala, Luis Miguel Zetina, Carlos Eduardo Zúñiga-Orlich
  8. Lipkovich, Olga

    1. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero
  9. Loirat, Delphine

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  10. López, Roberto Ivan

    1. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016
      Roberto Ivan López, Jenny Lissette Castro, Heidy Cedeño, Dagoberto Cisneros, Luis Corrales, Ileana González-Herrera, Mayté Lima-Pérez, Rogelio Prestol, Roberto Salinas, Jorge Luis Soriano-García, Alejandra T Zavala, Luis Miguel Zetina, Carlos Eduardo Zúñiga-Orlich

M

  1. Maehara, Yoshihiko

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  2. Manaka, Dai

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  3. Maranta, Angela Fischer

    1. Carboplatin dose based on actual renal function: no excess of acute haematotoxicity in adjuvant treatment in seminoma stage I
      Martin Fehr, Angela Fischer Maranta, Hermann Reichegger, Silke Gillessen, Richard Cathomas
  4. Mariani, Odette

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  5. Marous, Miguelle

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  6. Mas, Luis A

    1. Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
      Joseph A Pinto, Carlos S Vallejos, Luis E Raez, Luis A Mas, Rossana Ruiz, Junior S Torres-Roman, Zaida Morante, Jhajaira M Araujo, Henry L Gómez, Alfredo Aguilar, Denisse Bretel, Claudio J Flores, Christian Rolfo
  7. Masliah-Planchon, Julien

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  8. Mavroeidis, Leonidas

    1. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece
      Leonidas Mavroeidis, Vassiliki Metaxa-Mariatou, Alexandra Papoudou-Bai, Angeliki Maria Lampraki, Lida Kostadima, Ilias Tsinokou, George Zarkavelis, Alexandra Papadaki, Dimitrios Petrakis, Stefania Gκoura, Eleftherios Kampletsas, George Nasioulas, Anna Batistatou, George Pentheroudakis
  9. Melaabi, Samia

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  10. Metaxa-Mariatou, Vassiliki

    1. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece
      Leonidas Mavroeidis, Vassiliki Metaxa-Mariatou, Alexandra Papoudou-Bai, Angeliki Maria Lampraki, Lida Kostadima, Ilias Tsinokou, George Zarkavelis, Alexandra Papadaki, Dimitrios Petrakis, Stefania Gκoura, Eleftherios Kampletsas, George Nasioulas, Anna Batistatou, George Pentheroudakis
  11. Milacek, Christopher

    1. Empirical antimicrobial treatment in haemato-/oncological patients with neutropenic sepsis
      Matthias Gerhard Vossen, Christopher Milacek, Florian Thalhammer
  12. Mizushima, Tsunekazu

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  13. Morante, Zaida

    1. Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
      Joseph A Pinto, Carlos S Vallejos, Luis E Raez, Luis A Mas, Rossana Ruiz, Junior S Torres-Roman, Zaida Morante, Jhajaira M Araujo, Henry L Gómez, Alfredo Aguilar, Denisse Bretel, Claudio J Flores, Christian Rolfo
  14. Morel, Claire

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  15. Mori, Masaki

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  16. Munemoto, Yoshinori

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  17. Muro, Kei

    1. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero
  18. Mytelka, Daniel S

    1. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero
  19. Mæhle, Lovise

    1. BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
      Jan Norum, Eli Marie Grindedal, Cecilie Heramb, Inga Karsrud, Sarah Louise Ariansen, Dag Erik Undlien, Ellen Schlichting, Lovise Mæhle

N

  1. Nakamura, Fumitaka

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  2. Nakamura, Masato

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  3. Nasioulas, George

    1. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece
      Leonidas Mavroeidis, Vassiliki Metaxa-Mariatou, Alexandra Papoudou-Bai, Angeliki Maria Lampraki, Lida Kostadima, Ilias Tsinokou, George Zarkavelis, Alexandra Papadaki, Dimitrios Petrakis, Stefania Gκoura, Eleftherios Kampletsas, George Nasioulas, Anna Batistatou, George Pentheroudakis
  4. Nasroulah, Federico

    1. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero
  5. Norum, Jan

    1. BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
      Jan Norum, Eli Marie Grindedal, Cecilie Heramb, Inga Karsrud, Sarah Louise Ariansen, Dag Erik Undlien, Ellen Schlichting, Lovise Mæhle

O

  1. Ohtsu, Atsushi

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori

P

  1. Papadaki, Alexandra

    1. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece
      Leonidas Mavroeidis, Vassiliki Metaxa-Mariatou, Alexandra Papoudou-Bai, Angeliki Maria Lampraki, Lida Kostadima, Ilias Tsinokou, George Zarkavelis, Alexandra Papadaki, Dimitrios Petrakis, Stefania Gκoura, Eleftherios Kampletsas, George Nasioulas, Anna Batistatou, George Pentheroudakis
  2. Papoudou-Bai, Alexandra

    1. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece
      Leonidas Mavroeidis, Vassiliki Metaxa-Mariatou, Alexandra Papoudou-Bai, Angeliki Maria Lampraki, Lida Kostadima, Ilias Tsinokou, George Zarkavelis, Alexandra Papadaki, Dimitrios Petrakis, Stefania Gκoura, Eleftherios Kampletsas, George Nasioulas, Anna Batistatou, George Pentheroudakis
  3. Park, Joon Oh

    1. Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability
      Junhun Cho, Young Hwan Chang, You Jeong Heo, Seungtae Kim, Nayoung KD Kim, Joon Oh Park, Won Ki Kang, Jeeyun Lee, Kyoung-Mee Kim
  4. Patsou, Efrossini D

    1. Response: Effects of physical activity on depressive symptoms during breast cancer survivorship: a meta-analysis of randomised control trials
      Efrossini D Patsou, Michalis V Karamouzis
  5. Pentheroudakis, George

    1. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece
      Leonidas Mavroeidis, Vassiliki Metaxa-Mariatou, Alexandra Papoudou-Bai, Angeliki Maria Lampraki, Lida Kostadima, Ilias Tsinokou, George Zarkavelis, Alexandra Papadaki, Dimitrios Petrakis, Stefania Gκoura, Eleftherios Kampletsas, George Nasioulas, Anna Batistatou, George Pentheroudakis
  6. Petrakis, Dimitrios

    1. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece
      Leonidas Mavroeidis, Vassiliki Metaxa-Mariatou, Alexandra Papoudou-Bai, Angeliki Maria Lampraki, Lida Kostadima, Ilias Tsinokou, George Zarkavelis, Alexandra Papadaki, Dimitrios Petrakis, Stefania Gκoura, Eleftherios Kampletsas, George Nasioulas, Anna Batistatou, George Pentheroudakis
  7. Pierron, Gaëlle

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  8. Pinto, Joseph A

    1. Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
      Joseph A Pinto, Carlos S Vallejos, Luis E Raez, Luis A Mas, Rossana Ruiz, Junior S Torres-Roman, Zaida Morante, Jhajaira M Araujo, Henry L Gómez, Alfredo Aguilar, Denisse Bretel, Claudio J Flores, Christian Rolfo
  9. Pons Tostivint, Elvire

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  10. Prestol, Rogelio

    1. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016
      Roberto Ivan López, Jenny Lissette Castro, Heidy Cedeño, Dagoberto Cisneros, Luis Corrales, Ileana González-Herrera, Mayté Lima-Pérez, Rogelio Prestol, Roberto Salinas, Jorge Luis Soriano-García, Alejandra T Zavala, Luis Miguel Zetina, Carlos Eduardo Zúñiga-Orlich

R

  1. Raez, Luis E

    1. Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
      Joseph A Pinto, Carlos S Vallejos, Luis E Raez, Luis A Mas, Rossana Ruiz, Junior S Torres-Roman, Zaida Morante, Jhajaira M Araujo, Henry L Gómez, Alfredo Aguilar, Denisse Bretel, Claudio J Flores, Christian Rolfo
  2. Reichegger, Hermann

    1. Carboplatin dose based on actual renal function: no excess of acute haematotoxicity in adjuvant treatment in seminoma stage I
      Martin Fehr, Angela Fischer Maranta, Hermann Reichegger, Silke Gillessen, Richard Cathomas
  3. Reinmuth, Niels

    1. New data: new options for front-line therapy in NSCLC?
      Niels Reinmuth
  4. Rolfo, Christian

    1. Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
      Joseph A Pinto, Carlos S Vallejos, Luis E Raez, Luis A Mas, Rossana Ruiz, Junior S Torres-Roman, Zaida Morante, Jhajaira M Araujo, Henry L Gómez, Alfredo Aguilar, Denisse Bretel, Claudio J Flores, Christian Rolfo
  5. Rouzier, Roman

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  6. Ruiz, Rossana

    1. Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
      Joseph A Pinto, Carlos S Vallejos, Luis E Raez, Luis A Mas, Rossana Ruiz, Junior S Torres-Roman, Zaida Morante, Jhajaira M Araujo, Henry L Gómez, Alfredo Aguilar, Denisse Bretel, Claudio J Flores, Christian Rolfo

S

  1. Sablin, Marie Paule

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  2. Saji, Shigetoyo

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  3. Salinas, Roberto

    1. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016
      Roberto Ivan López, Jenny Lissette Castro, Heidy Cedeño, Dagoberto Cisneros, Luis Corrales, Ileana González-Herrera, Mayté Lima-Pérez, Rogelio Prestol, Roberto Salinas, Jorge Luis Soriano-García, Alejandra T Zavala, Luis Miguel Zetina, Carlos Eduardo Zúñiga-Orlich
  4. Sashegyi, Andreas

    1. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero
  5. Schleiermacher, Gudrun

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  6. Schlichting, Ellen

    1. BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
      Jan Norum, Eli Marie Grindedal, Cecilie Heramb, Inga Karsrud, Sarah Louise Ariansen, Dag Erik Undlien, Ellen Schlichting, Lovise Mæhle
  7. Servois, Vincent

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  8. Shiozawa, Manabu

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  9. Soriano-García, Jorge Luis

    1. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016
      Roberto Ivan López, Jenny Lissette Castro, Heidy Cedeño, Dagoberto Cisneros, Luis Corrales, Ileana González-Herrera, Mayté Lima-Pérez, Rogelio Prestol, Roberto Salinas, Jorge Luis Soriano-García, Alejandra T Zavala, Luis Miguel Zetina, Carlos Eduardo Zúñiga-Orlich

T

  1. T Zavala, Alejandra

    1. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016
      Roberto Ivan López, Jenny Lissette Castro, Heidy Cedeño, Dagoberto Cisneros, Luis Corrales, Ileana González-Herrera, Mayté Lima-Pérez, Rogelio Prestol, Roberto Salinas, Jorge Luis Soriano-García, Alejandra T Zavala, Luis Miguel Zetina, Carlos Eduardo Zúñiga-Orlich
  2. Tabernero, Josep

    1. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero
  3. Takagane, Akinori

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  4. Taniguchi, Hiroki

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  5. Thalhammer, Florian

    1. Empirical antimicrobial treatment in haemato-/oncological patients with neutropenic sepsis
      Matthias Gerhard Vossen, Christopher Milacek, Florian Thalhammer
  6. Torres-Roman, Junior S

    1. Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
      Joseph A Pinto, Carlos S Vallejos, Luis E Raez, Luis A Mas, Rossana Ruiz, Junior S Torres-Roman, Zaida Morante, Jhajaira M Araujo, Henry L Gómez, Alfredo Aguilar, Denisse Bretel, Claudio J Flores, Christian Rolfo
  7. Tresca, Patricia

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  8. Tsinokou, Ilias

    1. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece
      Leonidas Mavroeidis, Vassiliki Metaxa-Mariatou, Alexandra Papoudou-Bai, Angeliki Maria Lampraki, Lida Kostadima, Ilias Tsinokou, George Zarkavelis, Alexandra Papadaki, Dimitrios Petrakis, Stefania Gκoura, Eleftherios Kampletsas, George Nasioulas, Anna Batistatou, George Pentheroudakis

U

  1. Undlien, Dag Erik

    1. BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
      Jan Norum, Eli Marie Grindedal, Cecilie Heramb, Inga Karsrud, Sarah Louise Ariansen, Dag Erik Undlien, Ellen Schlichting, Lovise Mæhle

V

  1. Vaflard, Pauline

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  2. Vallejos, Carlos S

    1. Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
      Joseph A Pinto, Carlos S Vallejos, Luis E Raez, Luis A Mas, Rossana Ruiz, Junior S Torres-Roman, Zaida Morante, Jhajaira M Araujo, Henry L Gómez, Alfredo Aguilar, Denisse Bretel, Claudio J Flores, Christian Rolfo
  3. Van Cutsem, Eric

    1. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero
  4. Viglietti, Giulia

    1. Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?
      Matteo Lambertini, Giulia Viglietti, Evandro de Azambuja
  5. Vincent-Salomon, Anne

    1. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
      Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon, Sophie Gardrat, Marion Lavigne, Benjamin Bonsang, Pauline Vaflard, Elvire Pons Tostivint, Coraline Dubot, Delphine Loirat, Miguelle Marous, Romain Geiss, Nathalie Clément, Gudrun Schleiermacher, Choumouss Kamoun, Elodie Girard, Maude Ardin, Camille Benoist, Virginie Bernard, Odette Mariani, Roman Rouzier, Patricia Tresca, Vincent Servois, Anne Vincent-Salomon, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
  6. Vossen, Matthias Gerhard

    1. Empirical antimicrobial treatment in haemato-/oncological patients with neutropenic sepsis
      Matthias Gerhard Vossen, Christopher Milacek, Florian Thalhammer

W

  1. Weber, Jeffrey

    1. Recent advances in adjuvant therapy for patients with melanoma
      Jeffrey Weber

Y

  1. Yamanaka, Takeharu

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
  2. Yoshino, Takayuki

    1. Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
      Masahito Kotaka, Takeharu Yamanaka, Takayuki Yoshino, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Makio Gamoh, Manabu Shiozawa, Shigetoyo Saji, Yoshihiko Maehara, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
    2. Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set
      Axel Grothey, Takayuki Yoshino, Gyorgy Bodoky, Tudor Ciuleanu, Rocio Garcia-Carbonero, Pilar García-Alfonso, Eric Van Cutsem, Kei Muro, Daniel S Mytelka, Li Li, Olga Lipkovich, Yanzhi Hsu, Andreas Sashegyi, David Ferry, Federico Nasroulah, Josep Tabernero

Z

  1. Zarkavelis, George

    1. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece
      Leonidas Mavroeidis, Vassiliki Metaxa-Mariatou, Alexandra Papoudou-Bai, Angeliki Maria Lampraki, Lida Kostadima, Ilias Tsinokou, George Zarkavelis, Alexandra Papadaki, Dimitrios Petrakis, Stefania Gκoura, Eleftherios Kampletsas, George Nasioulas, Anna Batistatou, George Pentheroudakis
  2. Zetina, Luis Miguel

    1. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016
      Roberto Ivan López, Jenny Lissette Castro, Heidy Cedeño, Dagoberto Cisneros, Luis Corrales, Ileana González-Herrera, Mayté Lima-Pérez, Rogelio Prestol, Roberto Salinas, Jorge Luis Soriano-García, Alejandra T Zavala, Luis Miguel Zetina, Carlos Eduardo Zúñiga-Orlich
  3. Zúñiga-Orlich, Carlos Eduardo

    1. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016
      Roberto Ivan López, Jenny Lissette Castro, Heidy Cedeño, Dagoberto Cisneros, Luis Corrales, Ileana González-Herrera, Mayté Lima-Pérez, Rogelio Prestol, Roberto Salinas, Jorge Luis Soriano-García, Alejandra T Zavala, Luis Miguel Zetina, Carlos Eduardo Zúñiga-Orlich